Lexicon Pharmaceuticals, Inc. - Common Stock (NQ:LXRX)
2.340
+0.020
(+0.86%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 17, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 3,530,414 |
| Open | 2.310 |
| Bid (Size) | 2.290 (200) |
| Ask (Size) | 2.350 (700) |
| Prev. Close | 2.320 |
| Today's Range | 2.289 - 2.390 |
| 52wk Range | 1.030 - 2.680 |
| Shares Outstanding | 144,474,452 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Lexicon (LXRX) Q1 2026 Earnings Transcript ↗
June 01, 2026
Lexicon (LXRX) Q4 2025 Earnings Call Transcript ↗
March 05, 2026
Frequently Asked Questions
Is Lexicon Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Lexicon Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Lexicon Pharmaceuticals, Inc. - Common Stock trade on?
Lexicon Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Lexicon Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Lexicon Pharmaceuticals, Inc. - Common Stock is LXRX on the Nasdaq Stock Market
What is the current price of Lexicon Pharmaceuticals, Inc. - Common Stock?
The current price of Lexicon Pharmaceuticals, Inc. - Common Stock is 2.340
When was Lexicon Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Lexicon Pharmaceuticals, Inc. - Common Stock was at 08/17/26 04:00 PM ET
What is the market capitalization of Lexicon Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Lexicon Pharmaceuticals, Inc. - Common Stock is 338.07M
How many shares of Lexicon Pharmaceuticals, Inc. - Common Stock are outstanding?
Lexicon Pharmaceuticals, Inc. - Common Stock has 338M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.